Viewing Study NCT00760266


Ignite Creation Date: 2025-12-24 @ 4:20 PM
Ignite Modification Date: 2026-03-01 @ 10:21 PM
Study NCT ID: NCT00760266
Status: COMPLETED
Last Update Posted: 2011-04-04
First Post: 2008-09-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hypertension View
None older population View
None aliskiren View
None hydrochlorothiazide View
None systolic blood pressure View
None diastolic blood pressure View
None amlodipine, stage 2 View